Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 80255 BALTIMORE, MD
Back to RXRX Full portfolio

Position in RXRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,642,755
+$921,265 QoQ
Shares Held
720,097
+28.4% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 344 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. RXRX ranks #145 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,678,047 $2,484,611,664
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,529,709 $953,834,749
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,728,421 $858,558,562
4 KYMR
Kymera Therapeutics, Inc.
 7,112,980 $815,645,416
5 RPRX
Royalty Pharma plc
 11,193,657 $627,628,347
6 RVMD
Revolution Medicines, Inc.
 2,969,853 $447,655,945
7 MRNA
Moderna, Inc.
 5,589,560 $391,436,886
8 TWST
Twist Bioscience Corp
 3,634,652 $373,932,997

All Filings in RXRX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,642,755 720,097
2026-03-31 $1,721,490 560,746
2025-12-31 $1,698,834 415,363
2025-09-30 $1,556,153 318,884
2025-06-30 $1,425,235 281,667
2025-03-31 $1,186,197 224,234
2024-12-31 $892,252 131,990
2024-09-30 $740,966 112,438
2024-06-30 $660,862 88,115
2024-03-31 $618,788 62,065
2023-12-31 $557,721 56,564
2023-09-30 $405,258 52,975
2023-06-30 $573,890 76,826
2023-03-31 $498,869 74,793
2022-12-31 $585,335 75,919
2022-09-30 $385,231 36,206
2022-06-30 $185,592 22,800
2022-03-31 $4,025,280 562,190
2021-12-31 $14,690,225 857,573
2021-09-30 $13,361,216 580,670
2021-06-30 $21,282,602 583,085